Roper Technologies (ROP)
336.71
-13.98 (3.99%)
Upcoming Events
Latest Headlines
Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges
July 22, 2026 9:00 AM - PR NewsWire
Raymond James Downgrades Roper Industries (ROP) to Market Perform
July 22, 2026 5:55 AM - StreetInsider
Roper Industries (ROP) PT Lowered to $335 at Mizuho
July 21, 2026 6:51 AM - StreetInsider
Roche names new diagnostics North America chief, effective Aug. 1
July 20, 2026 8:20 AM - StreetInsider
Roche Appoints Dan Malarek as President and CEO of Roche Diagnostics North America
July 20, 2026 8:20 AM - PR NewsWire
FDA grants priority review to Genentech's Gazyva for kidney disease
July 15, 2026 1:01 AM - StreetInsider
FDA Grants Priority Review to Genentech’s Gazyva for Adults With Primary Membranous Nephropathy
July 15, 2026 1:01 AM - BizWire
Aderant CEO Chris Cartrett to depart for ImageTrend role
July 14, 2026 10:00 AM - StreetInsider
Aderant’s Chris Cartrett to Conclude Tenure as President & CEO
July 14, 2026 10:00 AM - BizWire
BMO Capital Starts Roper Industries (ROP) at Market Perform
July 10, 2026 2:41 AM - StreetInsider
BMO Capital Starts Roper Industries (ROP) at Market Perform
July 10, 2026 2:41 AM - StreetInsider
DAT: Dry van spot rates top contract for first time since February 2022; flatbed rates hit record high
July 9, 2026 10:20 AM - Globe NewsWire
Genentech and Roche Present New Data in Alzheimer’s Disease From Across Its Integrated Pharmaceutical and Diagnostics Portfolio at AAIC
July 7, 2026 1:01 AM - BizWire
Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer
July 2, 2026 1:10 AM - BizWire
Form S-8 ROPER TECHNOLOGIES INC
July 1, 2026 3:31 PM - SEC Filing
Roper Technologies schedules second quarter 2026 financial results conference call
July 1, 2026 8:00 AM - StreetInsider
FDA grants priority review to Genentech's Enspryng for thyroid eye disease
June 30, 2026 1:09 AM - StreetInsider
FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
June 30, 2026 1:09 AM - BizWire
U.S. Bank and DAT: Truck freight rates accelerate
June 29, 2026 9:00 AM - BizWire
DAT introduces Load Recommendations to help carriers find freight faster in DAT One
June 25, 2026 10:00 AM - StreetInsider
Form 11-K ROPER TECHNOLOGIES INC For: Dec 31
June 22, 2026 5:26 PM - SEC Filing
Form 11-K ROPER TECHNOLOGIES INC For: Dec 31
June 22, 2026 5:25 PM - SEC Filing
FDA accepts Genentech's application for Lunsumio and Polivy combo
June 18, 2026 1:00 AM - StreetInsider
FDA Accepts Supplemental Biologics License Application for Genentech’s Lunsumio and Polivy Combination for People With Relapsed or Refractory Large B-Cell Lymphoma
June 18, 2026 1:00 AM - BizWire
Chartwell Law Selects Aderant Expert Sierra to Drive Cloud Transformation, Supporting Firmwide Growth
June 17, 2026 9:01 AM - BizWire
DAT: Spot truckload rates rise in May on capacity pressure across the market
June 16, 2026 9:30 AM - StreetInsider
DAT’s Convoy Platform now shows reload options before carriers book
June 11, 2026 10:00 AM - StreetInsider
FDA grants priority review for Genentech's Tecentriq in stage III colon cancer
June 11, 2026 1:05 AM - StreetInsider
FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer
June 11, 2026 1:05 AM - BizWire
Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies
June 11, 2026 1:00 AM - PR NewsWire
Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology
June 8, 2026 1:00 AM - Globe NewsWire
Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection
June 4, 2026 11:34 AM - PR NewsWire
FDA Accepts New Drug Application for Genentech’s Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting
June 2, 2026 1:05 AM - BizWire
Genentech to present obesity drug data at diabetes conference
June 1, 2026 1:01 AM - StreetInsider
Genentech to Present New Data Advancing Its Obesity Portfolio at the American Diabetes Association’s 2026 Scientific Sessions
June 1, 2026 1:01 AM - BizWire
Form 4 ROPER TECHNOLOGIES INC For: May 20 Filed by: ESTEVES IRENE M
May 21, 2026 4:33 PM - SEC Filing
Form 4 ROPER TECHNOLOGIES INC For: May 20 Filed by: ARCHAMBEAU SHELLYE L
May 21, 2026 4:31 PM - SEC Filing
Form 4 ROPER TECHNOLOGIES INC For: May 20 Filed by: Joyce Thomas Patrick JR
May 21, 2026 4:30 PM - SEC Filing
Form 4 ROPER TECHNOLOGIES INC For: May 20 Filed by: BRINKLEY AMY WOODS
May 21, 2026 4:29 PM - SEC Filing
Form 4 ROPER TECHNOLOGIES INC For: May 20 Filed by: JOHNSON ROBERT D
May 21, 2026 4:27 PM - SEC Filing
Form 4 ROPER TECHNOLOGIES INC For: May 20 Filed by: Murphy John Francis
May 21, 2026 4:26 PM - SEC Filing
Form 4 ROPER TECHNOLOGIES INC For: May 20 Filed by: Thatcher Laura G
May 21, 2026 4:25 PM - SEC Filing
Form 4 ROPER TECHNOLOGIES INC For: May 20 Filed by: WALLMAN RICHARD F
May 21, 2026 4:24 PM - SEC Filing
Form S-8 ROPER TECHNOLOGIES INC
May 19, 2026 4:03 PM - SEC Filing
Form 8-K ROPER TECHNOLOGIES INC For: May 19
May 19, 2026 3:05 PM - SEC Filing
Illumia appoints Laura Newell-McLaughlin as Chief Operating Officer
May 19, 2026 2:16 PM - StreetInsider
Illumia Names Laura Newell-McLaughlin Chief Operating Officer
May 19, 2026 2:16 PM - BizWire
Roper Technologies (ROP) Declares $0.91 Quarterly Dividend; 1.1% Yield
May 19, 2026 2:00 PM - StreetInsider
Roper Technologies announces dividend
May 19, 2026 2:00 PM - Globe NewsWire
Genentech presents new giredestrant breast cancer data at ASCO 2026
May 19, 2026 1:05 AM - StreetInsider
Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant's Potential to Transform the Treatment Paradigm in Early Breast Cancer
May 19, 2026 1:05 AM - BizWire
DAT: Higher fuel costs lifted April truckload rates; freight volumes eased
May 18, 2026 10:05 AM - Globe NewsWire
Form SCHEDULE 13G ROPER TECHNOLOGIES INC Filed by: WINDACRE PARTNERSHIP LLC
May 15, 2026 4:01 PM - SEC Filing
FDA approves Genentech's Tecentriq for bladder cancer with ctDNA guidance
May 15, 2026 12:45 PM - StreetInsider
FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment
May 15, 2026 12:45 PM - BizWire
Aderant launches AI agent center for law firm operations
May 12, 2026 10:01 AM - StreetInsider
Aderant Introduces Agentic Law Firm Operations AI Agent Center
May 12, 2026 10:00 AM - BizWire
Form SD ROPER TECHNOLOGIES INC
May 6, 2026 4:10 PM - SEC Filing
DAT Brings Shipper-Focused Freight Intelligence to Gartner Supply Chain Symposium/Xpo™
May 4, 2026 10:00 AM - Globe NewsWire
Form 10-Q ROPER TECHNOLOGIES INC For: Mar 31
May 1, 2026 5:22 PM - SEC Filing
Form SCHEDULE 13G ROPER TECHNOLOGIES INC Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 30, 2026 1:04 PM - SEC Filing
Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026
April 30, 2026 1:00 AM - BizWire
Form SCHEDULE 13G ROPER TECHNOLOGIES INC Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC
April 29, 2026 3:10 PM - SEC Filing
Illumia Invests in Chennai Global Capability Center to Drive Technology and Product Innovation
April 28, 2026 11:30 PM - BizWire
PCS Software Integrates DAT One Load Board Directly into Cortex Opportunity Manager and Backhaul Booster
April 28, 2026 8:00 AM - PR NewsWire
Raymond James on Roper Industries (ROP): 'Buybacks Replace Deals As Earnings Risk & Multiple Have Both Declined'
April 24, 2026 10:52 AM - StreetInsider
Roper Industries (ROP) PT Raised to $407 at RBC Capital
April 24, 2026 10:06 AM - StreetInsider
Roper Industries (ROP) PT Raised to $540 at Piper Sandler
April 24, 2026 9:01 AM - StreetInsider
Genentech Partners With Comedy Icon Damon Wayans and diaTribe to Address Diabetes-Related Vision Loss With ‘All Eyes on DME’ Campaign
April 24, 2026 8:00 AM - BizWire
Roper Industries (ROP) PT Raised to $470 at Baird
April 24, 2026 6:26 AM - StreetInsider
Roper Industries (ROP) PT Lowered to $373 at Barclays
April 24, 2026 2:42 AM - StreetInsider
Full Article List
